Home › Funds › Lynx1 Capital Management LP › VYNE

Lynx1 Capital Management LP position in VYNE

VYNE THERAPEUTICS INC

Lynx1 Capital Management LP reported holding 1,628,700 shares of VYNE (VYNE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$1.1M, representing 0.12% of its reported portfolio and ranking #14 among its reported holdings. Lynx1 Capital Management LP has disclosed VYNE holdings in 4 of the last 9 reported quarters, going back to Q2 2024.

Latest position (Q2 2026)1.63M sh
Reported value held$1.06M
Portfolio Weight0.12%
First reportedQ2 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Lynx1 Capital Management LP's VYNE position evolved

Lynx1 Capital Management LP first disclosed a stake in VYNE in Q2 2024 at 16,194 shares (US$32K). The position peaked in Q2 2026 at 1,628,700 shares, worth US$1.1M. Across 4 filings, Lynx1 Capital Management LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 1,628,700 shares valued at US$1.1M.

Quarter by quarter

QuarterSharesValueChange
Q2 2024 16.19K $31.90K New
Q3 2024 16.19K $30.45K Hold
Q1 2026 1.63M $973.15K New
Q2 2026 1.63M $1.06M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VYNE and 13F data

VYNE (VYNE THERAPEUTICS INC) is a company whose sector is not yet classified in our data. 28 other funds we track also report a position in VYNE — the largest reported positions include KVP Capital Advisors, LP (US$326K), SUPERSTRING CAPITAL MANAGEMENT LP (US$40K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VYNE

All VYNE fund holders →

FAQ

How long has Lynx1 Capital Management LP held VYNE?

Lynx1 Capital Management LP has disclosed VYNE holdings in 4 of the last 9 reported quarters, going back to Q2 2024.

What is Lynx1 Capital Management LP's current position in VYNE?

As of Q2 2026, Lynx1 Capital Management LP holds 1.63M shares of VYNE (VYNE THERAPEUTICS INC), valued at $1.06M, representing 0.12% of its reported portfolio and ranking #14.

Has Lynx1 Capital Management LP been buying or selling VYNE?

In the latest 13F filing (Q2 2026), Lynx1 Capital Management LP held unchanged its position in VYNE. The position peaked in Q2 2026 at 1.63M shares.

Which other funds hold VYNE?

Other major institutional holders of VYNE include KVP Capital Advisors, LP, SUPERSTRING CAPITAL MANAGEMENT LP, among 28 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.